PMC:7396557 / 31006-31250
Annnotations
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T284 | 0-1 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T285 | 158-159 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T263 | 132-137 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T264 | 208-213 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T238 | 0-244 | Sentence | denotes | A total of 680 patients in eight randomized controlled trials (RCTs) were included in the research, and the results showed that the group receiving HXZQC had a significantly better clinical response than the group using Western medicines alone. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 872 | 15-23 | Species | denotes | patients | Tax:9606 |